Relapsed or refractory B-cell acute lymphoblastic leukemia

Clinical trials for Relapsed or refractory B-cell acute lymphoblastic leukemia explained in plain language.

Never miss a new study

Get alerted when new Relapsed or refractory B-cell acute lymphoblastic leukemia trials appear

Sign up with your email to follow new studies for Relapsed or refractory B-cell acute lymphoblastic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 4 Completed 2

Colombia-Made CAR-T cells put to the test against stubborn blood cancers

Cure Not yet recruiting

Researchers are running a first-in-human Phase I trial of COL01, an experimental CAR-T cell therapy that targets the CD19 marker on B cells. The study enrolls adults with relapsed or refractory B-cell cancers, including diffuse large B-cell lymphoma, mantle cell lymphoma, follicu…

Matched conditions: RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Phase 1 • Sponsor: GUSTAVO SALGUERO • Aim: Cure

Last updated Oct 21, 2026 18:00 UTC

Relapsed or refractory B-cell acute lymphoblastic leukemia

Get alerted when new Relapsed or refractory B-cell acute lymphoblastic leukemia trials appear

Colombia-Made CAR-T cells put to the test against stubborn blood cancers